INDV
IndiviorยทNASDAQ
--
--(--)
--
--(--)
INDV Profile
Indivior Pharmaceuticals, Inc.
A global specialty pharmaceutical company and a global leader in the treatment of opioid dependence
10710 Midlothian Turnpike, Suite 125, North Chesterfield , VA 23235
--
Indivior Pharmaceuticals, Inc., was incorporated as a public limited company under the laws of England and Wales on September 26, 2014 and re-registered in Delaware on January 26, 2026. Indivior is committed to improving the lives of patients through the development of drugs to treat opioid use disorder (OUD). Based on its existing OUD therapeutic portfolio, Indivior has a portfolio of product candidates designed to further expand its business in this field.
